According to our previous proteogenomics landscapeof the Taiwan Cancer Moonshot cohort consisting of 89 lung adenocarcinomapatients in East Asia, the upregulationof OCIAD2 protein was observed in 95.5% (85/89) patients by comparingOCIAD2 level of tumor parts (T) with that in matched normal adjacenttissues (N), implying a strong correlation between high OCIAD2 expressionlevel and the presence of lung adenocarcinoma (Figure A). The gene discussed is OCIAD2; the disease is lung adenocarcinoma.